RESHAPE INTEGRATED DUAL BALLOON SYSTEM, RESHAPE BALLOON ASSEMBLY, RESHAPE REMOVAL CATHETER, RESHAPE VALVE SEALANT

Implant, Intragastric For Morbid Obesity

FDA Premarket Approval P140012 S004

This medical device record is a pma supplement. A supplement may have changed the device description/function or indication from that approved in the original pma. Be sure to look at the original pma record for more information.

Pre-market Approval Supplement Details

Addition of vesta, inc. , as a second source supplier of the balloon shell (p/n 03-0238).

DeviceRESHAPE INTEGRATED DUAL BALLOON SYSTEM, RESHAPE BALLOON ASSEMBLY, RESHAPE REMOVAL CATHETER, RESHAPE VALVE SEALANT
Classification NameImplant, Intragastric For Morbid Obesity
Generic NameImplant, Intragastric For Morbid Obesity
ApplicantAppollo Endosurgery
Date Received2015-12-01
Decision Date2015-12-31
PMAP140012
SupplementS004
Product CodeLTI
Advisory CommitteeGastroenterology/Urology
Supplement Type30-day Notice
Supplement ReasonProcess Change - Manufacturer/sterilizer/packager/supplier
Expedited ReviewNo
Combination Product No
Applicant Address Appollo Endosurgery 1120 S Capital Of Tx Hwy bldg 1, Ste 300 austin, TX 78746

Supplemental Filings

Supplement NumberDateSupplement Type
P140012Original Filing
S013 2018-05-02 Special (immediate Track)
S012 2018-02-26 Normal 180 Day Track No User Fee
S011 2017-09-27 30-day Notice
S010 2017-04-28 Normal 180 Day Track No User Fee
S009 2017-03-22 Special (immediate Track)
S008 2017-01-23 30-day Notice
S007 2016-12-19 30-day Notice
S006 2016-12-07 30-day Notice
S005 2016-09-26 30-day Notice
S004 2015-12-01 30-day Notice
S003 2015-11-18 Real-time Process
S002 2015-09-28 Normal 180 Day Track
S001 2015-08-26 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
B001RSM9001 P140012 000
B001RSM2101 P140012 000
B001RSM1011 P140012 000
B001RSM1101 P140012 002

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.